Profile data is unavailable for this security.
About the company
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, science, video and other products. The Company operates in five business segments. The Endoscopy segment provides gastrointestinal endoscopy, surgical endoscopy, endoscopy systems and repair services. The Therapeutic Equipment segment provides endoscopic treatment tools, energy devices, urology, gynecology and otolaryngology products. The Scientific segment provides biological microscope, industrial microscope, industrial endoscope and non-destructive inspection equipment. The Imaging segment provides digital cameras and recording machines. The Others segment is engaged in the manufacture and sale of biomaterials. The Company is also engaged in the financial investment business.
- Revenue in JPY (TTM)880.66bn
- Net income in JPY133.54bn
- Incorporated1919
- Employees31.56k
- LocationOlympus CorpShinjuku Monolith, 2-3-1, Nishi-ShinjukuSHINJUKU-KU 163-0914JapanJPN
- Phone+81 333402111
- Fax+81 333402062
- Websitehttps://www.olympus.co.jp/
Mergers & acquisitions
Acquired company | 7733:TYO since announced | Transaction value |
---|---|---|
Taewoong Medical Co Ltd | -0.40% | 370.00m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASAHI INTECC CO., LTD. | 85.48bn | 11.95bn | 600.04bn | 10.44k | 50.22 | 4.87 | 29.75 | 7.02 | 43.98 | 43.98 | 314.70 | 453.73 | 0.5697 | 1.18 | 5.74 | 8,191,759.00 | 8.05 | 10.83 | 9.26 | 12.70 | 65.63 | 67.67 | 14.14 | 16.97 | 2.68 | -- | 0.0985 | 27.03 | 26.41 | 12.73 | 8.74 | 7.04 | 11.91 | 9.55 |
MicroPort Scientific Corp | 104.43bn | -50.23bn | 616.76bn | 9.19k | -- | 3.81 | -- | 5.91 | -1.67 | -1.67 | 3.46 | 5.31 | 0.212 | 1.09 | 4.91 | 782,113.10 | -13.00 | -5.78 | -18.10 | -8.56 | 61.56 | 68.39 | -61.31 | -15.30 | 3.14 | -38.30 | 0.4091 | -- | 20.02 | 14.83 | -44.57 | -- | 34.78 | -- |
Shandong Weigao Group Medical Polymer Co | 266.38bn | 47.81bn | 937.61bn | 11.48k | 19.38 | 2.37 | 14.00 | 3.52 | 0.6358 | 0.6358 | 3.54 | 5.19 | 0.4443 | 3.79 | 2.60 | 1,438,283.00 | 8.69 | 7.94 | 11.38 | 9.79 | 51.38 | 59.02 | 19.56 | 18.66 | 2.67 | 43.69 | 0.1668 | 29.53 | 13.16 | 18.54 | 7.57 | 17.53 | 12.45 | 10.10 |
Fisher & Paykel Healthcare Corporatn Ltd | 119.37bn | 20.35bn | 1.23tn | 7.38k | 60.48 | 10.22 | 45.00 | 10.29 | 0.4325 | 0.4325 | 2.54 | 2.56 | 0.7113 | 1.66 | 6.77 | 199,633.90 | 12.13 | 21.95 | 14.52 | 26.98 | 61.01 | 64.59 | 17.05 | 22.79 | 0.8828 | 26.39 | 0.1019 | 47.97 | -14.69 | 13.46 | -28.10 | 17.38 | 21.94 | 15.16 |
Cochlear Limited | 148.79bn | 22.71bn | 1.29tn | 4.50k | 56.84 | 8.66 | 43.69 | 8.68 | 3.97 | 3.97 | 26.04 | 26.08 | 0.6993 | 1.61 | 4.83 | 380,622.20 | 10.67 | 9.70 | 12.89 | 12.88 | 75.46 | 74.70 | 15.26 | 12.49 | 2.22 | 46.41 | 0.1274 | 90.63 | 10.06 | 5.62 | -11.45 | 5.27 | 1.67 | -1.25 |
Shanghai United Img Hlthcare Co Ltd | 160.73bn | 29.41bn | 2.44tn | 5.48k | 89.52 | 7.69 | 347.50 | 15.21 | 1.74 | 1.74 | 10.16 | 20.27 | -- | -- | -- | 1,541,505.00 | -- | -- | -- | -- | 45.69 | -- | 18.06 | -- | 3.19 | -- | 0.0289 | -- | 25.91 | -- | 56.96 | -- | -- | -- |
Terumo Corp | 797.81bn | 87.30bn | 2.58tn | 28.29k | 29.76 | 2.39 | 16.60 | 3.23 | 115.88 | 115.88 | 1,057.78 | 1,442.01 | 0.5418 | 1.84 | 5.55 | 28,197,250.00 | 5.93 | 6.98 | 6.82 | 8.29 | 51.25 | 53.80 | 10.94 | 13.45 | 1.73 | 78.78 | 0.1775 | 25.19 | 14.57 | 6.47 | 14.94 | 10.06 | 13.93 | 10.12 |
FUJIFILM Holdings Corp | 2.76tn | 207.73bn | 2.69tn | 75.47k | 12.52 | 0.9645 | 7.75 | 0.9738 | 517.54 | 517.54 | 6,874.06 | 6,718.77 | 0.7008 | 3.01 | 4.80 | 36,557,370.00 | 5.20 | 4.68 | 6.70 | 6.15 | 39.52 | 40.54 | 7.41 | 6.90 | 1.22 | 160.81 | 0.1493 | 23.67 | 15.20 | 1.70 | 16.54 | 9.94 | 11.34 | 9.46 |
Olympus Corp | 880.66bn | 133.54bn | 2.87tn | 31.56k | 21.30 | 4.66 | 14.17 | 3.26 | 104.88 | 107.05 | 691.53 | 479.52 | 0.6558 | 1.70 | 5.27 | 27,906,800.00 | 9.96 | 5.83 | 13.41 | 8.36 | 67.40 | 64.40 | 15.19 | 7.81 | 1.55 | 356.83 | 0.3681 | 21.46 | 18.93 | 3.25 | 76.44 | 22.02 | 0.5139 | 14.87 |
Holder | Shares | % Held |
---|---|---|
Nomura Asset Management Co., Ltd.as of 28 Feb 2023 | 79.08m | 6.15% |
Baillie Gifford & Co.as of 30 Jun 2021 | 65.60m | 5.10% |
Capital Research & Management Co. (World Investors)as of 31 Dec 2022 | 53.68m | 4.18% |
Nikko Asset Management Co., Ltd.as of 03 Mar 2023 | 39.30m | 3.06% |
Daiwa Asset Management Co. Ltd.as of 28 Feb 2023 | 37.03m | 2.88% |
BlackRock Fund Advisorsas of 31 Oct 2022 | 36.93m | 2.87% |
The Vanguard Group, Inc.as of 03 Mar 2023 | 33.03m | 2.57% |
BlackRock Japan Co., Ltd.as of 31 Oct 2022 | 26.96m | 2.10% |
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 23 Jan 2023 | 20.19m | 1.57% |
Capital International Ltd.as of 02 Mar 2023 | 19.59m | 1.52% |